Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes

导出原文传递

翻译打印收藏纠错

作者： Efficace,F. ^[1] ; Cocks,K. ^[2] ; Breccia,M. ^[3] ; Sprangers,M. ^[4] ; Meyers,C.A. ^[5] ; Vignetti,M. ^[6] ; Baccarani,M. ; Mandelli,F.

作者单位： The University of Texas, M.D. Anderson Cancer Center, Department of Neuro-Oncology, Houston, TX ^[1] Italian Group for Adult Hematologic Diseases (GIMEMA), GIMEMA Data Center and Health Outcomes ^[2] University of Leeds, Clinical Trials Research Unit, Leeds, United Kingdom ^[3] University of Bologna, S. Orsola-Malpighi Hospital, Department of Hematology and Oncology, Bologna ^[4] University of Rome Sapienza, Department of Hematology, Rome, Italy ^[5] University of Amsterdam, Academic Medical Center, Department of Medical Psychology, Amsterdam ^[6]

关键词 Chronic myeloid leukemia Patient-reported outcomes Quality of life Systematic review

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交